226 related articles for article (PubMed ID: 21235748)
1. mGlu2 metabotropic glutamate receptors restrain inflammatory pain and mediate the analgesic activity of dual mGlu2/mGlu3 receptor agonists.
Zammataro M; Chiechio S; Montana MC; Traficante A; Copani A; Nicoletti F; Gereau RW
Mol Pain; 2011 Jan; 7():6. PubMed ID: 21235748
[TBL] [Abstract][Full Text] [Related]
2. Targeting group II metabotropic glutamate (mGlu) receptors for the treatment of psychosis associated with Alzheimer's disease: selective activation of mGlu2 receptors amplifies beta-amyloid toxicity in cultured neurons, whereas dual activation of mGlu2 and mGlu3 receptors is neuroprotective.
Caraci F; Molinaro G; Battaglia G; Giuffrida ML; Riozzi B; Traficante A; Bruno V; Cannella M; Merlo S; Wang X; Heinz BA; Nisenbaum ES; Britton TC; Drago F; Sortino MA; Copani A; Nicoletti F
Mol Pharmacol; 2011 Mar; 79(3):618-26. PubMed ID: 21159998
[TBL] [Abstract][Full Text] [Related]
3. Analgesic effects of the selective group II (mGlu2/3) metabotropic glutamate receptor agonists LY379268 and LY389795 in persistent and inflammatory pain models after acute and repeated dosing.
Jones CK; Eberle EL; Peters SC; Monn JA; Shannon HE
Neuropharmacology; 2005; 49 Suppl 1():206-18. PubMed ID: 15998527
[TBL] [Abstract][Full Text] [Related]
4. Differentiating the roles of mGlu2 and mGlu3 receptors using LY541850, an mGlu2 agonist/mGlu3 antagonist.
Hanna L; Ceolin L; Lucas S; Monn J; Johnson B; Collingridge G; Bortolotto Z; Lodge D
Neuropharmacology; 2013 Mar; 66():114-21. PubMed ID: 22445601
[TBL] [Abstract][Full Text] [Related]
5. The mGlu2 but not the mGlu3 receptor mediates the actions of the mGluR2/3 agonist, LY379268, in mouse models predictive of antipsychotic activity.
Woolley ML; Pemberton DJ; Bate S; Corti C; Jones DN
Psychopharmacology (Berl); 2008 Feb; 196(3):431-40. PubMed ID: 18057917
[TBL] [Abstract][Full Text] [Related]
6. Evidence for the role of metabotropic glutamate (mGlu)2 not mGlu3 receptors in the preclinical antipsychotic pharmacology of the mGlu2/3 receptor agonist (-)-(1R,4S,5S,6S)-4-amino-2-sulfonylbicyclo[3.1.0]hexane-4,6-dicarboxylic acid (LY404039).
Fell MJ; Svensson KA; Johnson BG; Schoepp DD
J Pharmacol Exp Ther; 2008 Jul; 326(1):209-17. PubMed ID: 18424625
[TBL] [Abstract][Full Text] [Related]
7. The use of knock-out mice unravels distinct roles for mGlu2 and mGlu3 metabotropic glutamate receptors in mechanisms of neurodegeneration/neuroprotection.
Corti C; Battaglia G; Molinaro G; Riozzi B; Pittaluga A; Corsi M; Mugnaini M; Nicoletti F; Bruno V
J Neurosci; 2007 Aug; 27(31):8297-308. PubMed ID: 17670976
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, pharmacological characterization, and molecular modeling of heterobicyclic amino acids related to (+)-2-aminobicyclo[3.1.0] hexane-2,6-dicarboxylic acid (LY354740): identification of two new potent, selective, and systemically active agonists for group II metabotropic glutamate receptors.
Monn JA; Valli MJ; Massey SM; Hansen MM; Kress TJ; Wepsiec JP; Harkness AR; Grutsch JL; Wright RA; Johnson BG; Andis SL; Kingston A; Tomlinson R; Lewis R; Griffey KR; Tizzano JP; Schoepp DD
J Med Chem; 1999 Mar; 42(6):1027-40. PubMed ID: 10090786
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological profiling of native group II metabotropic glutamate receptors in primary cortical neuronal cultures using a FLIPR.
Sanger H; Hanna L; Colvin EM; Grubisha O; Ursu D; Heinz BA; Findlay JD; Vivier RG; Sher E; Lodge D; Monn JA; Broad LM
Neuropharmacology; 2013 Mar; 66():264-73. PubMed ID: 22659090
[TBL] [Abstract][Full Text] [Related]
10. Activation of mGlu3 metabotropic glutamate receptors enhances GDNF and GLT-1 formation in the spinal cord and rescues motor neurons in the SOD-1 mouse model of amyotrophic lateral sclerosis.
Battaglia G; Riozzi B; Bucci D; Di Menna L; Molinaro G; Pallottino S; Nicoletti F; Bruno V
Neurobiol Dis; 2015 Feb; 74():126-36. PubMed ID: 25434487
[TBL] [Abstract][Full Text] [Related]
11. Anxiolytic-like activity of the mGLU2/3 receptor agonist LY354740 in the elevated plus maze test is disrupted in metabotropic glutamate receptor 2 and 3 knock-out mice.
Linden AM; Shannon H; Baez M; Yu JL; Koester A; Schoepp DD
Psychopharmacology (Berl); 2005 Apr; 179(1):284-91. PubMed ID: 15619115
[TBL] [Abstract][Full Text] [Related]
12. Activation of group II metabotropic glutamate receptors induces long-term depression of excitatory synaptic transmission in the substantia nigra pars reticulata.
Johnson KA; Niswender CM; Conn PJ; Xiang Z
Neurosci Lett; 2011 Oct; 504(2):102-106. PubMed ID: 21945652
[TBL] [Abstract][Full Text] [Related]
13. Activation of mGlu2/3 metabotropic glutamate receptors negatively regulates the stimulation of inositol phospholipid hydrolysis mediated by 5-hydroxytryptamine2A serotonin receptors in the frontal cortex of living mice.
Molinaro G; Traficante A; Riozzi B; Di Menna L; Curto M; Pallottino S; Nicoletti F; Bruno V; Battaglia G
Mol Pharmacol; 2009 Aug; 76(2):379-87. PubMed ID: 19439499
[TBL] [Abstract][Full Text] [Related]
14. HDAC and HAT inhibitors differently affect analgesia mediated by group II metabotropic glutamate receptors.
Zammataro M; Sortino MA; Parenti C; Gereau RW; Chiechio S
Mol Pain; 2014 Nov; 10():68. PubMed ID: 25406541
[TBL] [Abstract][Full Text] [Related]
15. Chronic treatment with a metabotropic mGlu2/3 receptor agonist diminishes behavioral response to a phenethylamine hallucinogen.
Halberstadt AL; van der Zee JVF; Chatha M; Geyer MA; Powell SB
Psychopharmacology (Berl); 2019 Feb; 236(2):821-830. PubMed ID: 30448990
[TBL] [Abstract][Full Text] [Related]
16. Regulation of group II metabotropic glutamate receptors by G protein-coupled receptor kinases: mGlu2 receptors are resistant to homologous desensitization.
Iacovelli L; Molinaro G; Battaglia G; Motolese M; Di Menna L; Alfiero M; Blahos J; Matrisciano F; Corsi M; Corti C; Bruno V; De Blasi A; Nicoletti F
Mol Pharmacol; 2009 Apr; 75(4):991-1003. PubMed ID: 19164443
[TBL] [Abstract][Full Text] [Related]
17. Selective activation of either mGlu2 or mGlu3 receptors can induce LTD in the amygdala.
Lucas SJ; Bortolotto ZA; Collingridge GL; Lodge D
Neuropharmacology; 2013 Mar; 66():196-201. PubMed ID: 22531751
[TBL] [Abstract][Full Text] [Related]
18. Astroglial mGlu3 receptors promote alpha-secretase-mediated amyloid precursor protein cleavage.
Durand D; Carniglia L; Beauquis J; Caruso C; Saravia F; Lasaga M
Neuropharmacology; 2014 Apr; 79():180-9. PubMed ID: 24291464
[TBL] [Abstract][Full Text] [Related]
19. A selective allosteric potentiator of metabotropic glutamate (mGlu) 2 receptors has effects similar to an orthosteric mGlu2/3 receptor agonist in mouse models predictive of antipsychotic activity.
Galici R; Echemendia NG; Rodriguez AL; Conn PJ
J Pharmacol Exp Ther; 2005 Dec; 315(3):1181-7. PubMed ID: 16123306
[TBL] [Abstract][Full Text] [Related]
20. Group II metabotropic glutamate receptor activation by agonist LY379268 treatment increases the expression of brain derived neurotrophic factor in the mouse brain.
Di Liberto V; Bonomo A; Frinchi M; Belluardo N; Mudò G
Neuroscience; 2010 Feb; 165(3):863-73. PubMed ID: 19909793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
